707 related articles for article (PubMed ID: 32360307)
1. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
Tanday N; Irwin N; Flatt PR; Moffett RC
Biochem Pharmacol; 2020 Jul; 177():114009. PubMed ID: 32360307
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide and sitagliptin counter beta- to alpha-cell transdifferentiation in diabetes.
Tanday N; Flatt PR; Irwin N; Moffett RC
J Endocrinol; 2020 Apr; 245(1):53-64. PubMed ID: 31977315
[TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
4. Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells.
Mohan S; Lafferty R; Tanday N; Flatt PR; Moffett RC; Irwin N
PLoS One; 2021; 16(12):e0261608. PubMed ID: 34929019
[TBL] [Abstract][Full Text] [Related]
5. Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice.
Millar PJ; Pathak V; Moffett RC; Pathak NM; Bjourson AJ; O'Kane MJ; Flatt PR; Gault VA
Mol Cell Endocrinol; 2016 Jan; 420():37-45. PubMed ID: 26607806
[TBL] [Abstract][Full Text] [Related]
6. Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice.
Lafferty RA; Tanday N; Moffett RC; Reimann F; Gribble FM; Flatt PR; Irwin N
Front Endocrinol (Lausanne); 2021; 12():633625. PubMed ID: 33716983
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin Does Not Directly Affect Human α or β Cells.
Dai C; Walker JT; Shostak A; Bouchi Y; Poffenberger G; Hart NJ; Jacobson DA; Calcutt MW; Bottino R; Greiner DL; Shultz LD; McGuinness OP; Dean ED; Powers AC
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32428240
[TBL] [Abstract][Full Text] [Related]
8. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
[TBL] [Abstract][Full Text] [Related]
9. Enzymatically stable analogue of the gut-derived peptide xenin on beta-cell transdifferentiation in high fat fed and insulin-deficient Ins1
Tanday N; Moffett RC; Gault VA; Flatt PR; Irwin N
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3384. PubMed ID: 32662136
[TBL] [Abstract][Full Text] [Related]
10. SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans.
Chae H; Augustin R; Gatineau E; Mayoux E; Bensellam M; Antoine N; Khattab F; Lai BK; Brusa D; Stierstorfer B; Klein H; Singh B; Ruiz L; Pieper M; Mark M; Herrera PL; Gribble FM; Reimann F; Wojtusciszyn A; Broca C; Rita N; Piemonti L; Gilon P
Mol Metab; 2020 Dec; 42():101071. PubMed ID: 32896668
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu
Sarnobat D; Moffett RC; Gault VA; Tanday N; Reimann F; Gribble FM; Flatt PR; Irwin N
Peptides; 2020 Mar; 125():170205. PubMed ID: 31738969
[TBL] [Abstract][Full Text] [Related]
12. Beneficial actions of a long-acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation.
Tanday N; Irwin N; Moffett RC; Flatt PR; O'Harte FPM
Diabetes Obes Metab; 2020 Dec; 22(12):2468-2478. PubMed ID: 32844576
[TBL] [Abstract][Full Text] [Related]
13. Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient GluCreERT2;ROSA26-eYFP diabetic mice.
Sarnobat D; Lafferty RA; Charlotte Moffett R; Tarasov AI; Flatt PR; Irwin N
J Pharm Pharmacol; 2022 Nov; 74(12):1758-1764. PubMed ID: 36206181
[TBL] [Abstract][Full Text] [Related]
14. Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin.
Zhang Y; Zhang Y; Bone RN; Cui W; Peng JB; Siegal GP; Wang H; Wu H
PLoS One; 2012; 7(5):e36675. PubMed ID: 22586489
[TBL] [Abstract][Full Text] [Related]
15. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
Millar P; Pathak N; Parthsarathy V; Bjourson AJ; O'Kane M; Pathak V; Moffett RC; Flatt PR; Gault VA
J Endocrinol; 2017 Sep; 234(3):255-267. PubMed ID: 28611211
[TBL] [Abstract][Full Text] [Related]
17. Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP mice.
Tanday N; Coulter-Parkhill A; Moffett RC; Suruli K; Dubey V; Flatt PR; Irwin N
J Endocrinol; 2023 Nov; 259(2):. PubMed ID: 37650517
[TBL] [Abstract][Full Text] [Related]
18. Transdifferentiation of both intra- and extra-islet cells into beta cells in nicotinamide treated neonatal diabetic rats: An in situ hybridization and double immunohistochemical study.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2020 Oct; 122(7):151612. PubMed ID: 33066834
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin suppresses glucagon signaling in rodent models of diabetes.
Wang MY; Yu X; Lee Y; McCorkle SK; Chen S; Li J; Wang ZV; Davidson JA; Scherer PE; Holland WL; Unger RH; Roth MG
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6611-6616. PubMed ID: 28584109
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Bonner C; Kerr-Conte J; Gmyr V; Queniat G; Moerman E; Thévenet J; Beaucamps C; Delalleau N; Popescu I; Malaisse WJ; Sener A; Deprez B; Abderrahmani A; Staels B; Pattou F
Nat Med; 2015 May; 21(5):512-7. PubMed ID: 25894829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
